Inhibition of factor b, the alternative complement pathway...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C12P 21/08 (2006.01)

Patent

CA 2561531

Disclosed are novel inhibitors of the alternative complement pathway and particularly, novel anti-factor B antibodies. Also disclosed is the use of such inhibitors to reduce or prevent airway hyperresponsiveness and/or airway inflammation by selectively inhibiting the alternative complement pathway, thereby treating diseases in which such conditions play a role. Also disclosed is the use of such inhibitors to reduce or prevent other diseases and conditions, including ischemia-reperfusion injury, by inhibition of the alternative complement pathway.

L'invention concerne de nouveaux inhibiteurs de la voie du complément alternative, en particulier de nouveaux anticorps anti-facteur B. L'invention concerne également l'utilisation de ces inhibiteurs dans l'atténuation ou la prévention de l'hypersensibilité des voies aériennes et/ou des inflammations des voies aériennes, par l'inhibition sélective de la voie du complément alternative, ce qui permet de traiter les maladies dans lesquelles ces états jouent un rôle. L'invention concerne également l'utilisation de ces inhibiteurs dans l'atténuation ou la prévention d'autres maladies ou états, notamment les lésions d'ischémie-reperfusion, par l'inhibition de la voie du complément alternative.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of factor b, the alternative complement pathway... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of factor b, the alternative complement pathway..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of factor b, the alternative complement pathway... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1925044

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.